Mallon PW - Search Results

1

Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.

Martin A, Moore C, Mallon PW, Hoy J, Emery S, Belloso W, Phanuphak P, Ferret S, Cooper DA, Boyd MA; Second Line study team. Martin A, et al. Among authors: mallon pw. AIDS. 2013 Sep 24;27(15):2403-11. doi: 10.1097/01.aids.0000432534.47217.b4. AIDS. 2013. PMID: 23921615 Free PMC article. Clinical Trial.

2

HIV-associated lipodystrophy.

Mallon PW, Cooper DA, Carr A. Mallon PW, et al. HIV Med. 2001 Jul;2(3):166-73. doi: 10.1046/j.1468-1293.2001.00071.x. HIV Med. 2001. PMID: 11737397 Free article. Review.

3

Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals.

Mallon PW, Ray J, Cooper DA. Mallon PW, et al. J Clin Virol. 2003 Feb;26(2):223-7. doi: 10.1016/s1386-6532(02)00120-8. J Clin Virol. 2003. PMID: 12600653

4

HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways.

Mallon PW, Carr A, Cooper DA. Mallon PW, et al. Curr Diab Rep. 2002 Apr;2(2):116-24. doi: 10.1007/s11892-002-0070-x. Curr Diab Rep. 2002. PMID: 12643131 Review.

5

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy.

Mallon PW, Miller J, Cooper DA, Carr A. Mallon PW, et al. AIDS. 2003 May 2;17(7):971-9. doi: 10.1097/00002030-200305020-00005. AIDS. 2003. PMID: 12700446

6

Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.

Mallon PW, Wand H, Law M, Miller J, Cooper DA, Carr A; HIV Lipodystrophy Case Definition Study; Australian Lipodystrophy Prevalence Survey Investigators. Mallon PW, et al. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):156-62. doi: 10.1097/01.qai.0000147527.64863.1a. J Acquir Immune Defic Syndr. 2005. PMID: 15671800

7

Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.

Kovacic JC, Martin A, Carey D, Wand H, Mallon PW, Feneley MP, Emery S, Cooper DA, Carr A; ROSEY Investigators. Kovacic JC, et al. Among authors: mallon pw. Antivir Ther. 2005;10(1):135-43. Antivir Ther. 2005. PMID: 15751771 Clinical Trial.

8

Therapeutic approaches to combating lipoatrophy: do they work?

Martin A, Mallon PW. Martin A, et al. Among authors: mallon pw. J Antimicrob Chemother. 2005 May;55(5):612-5. doi: 10.1093/jac/dki062. Epub 2005 Mar 10. J Antimicrob Chemother. 2005. PMID: 15761072 Review.

9

In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, Cooper DA, Carr A; SAMA Investigators. Mallon PW, et al. J Infect Dis. 2005 May 15;191(10):1686-96. doi: 10.1086/429697. Epub 2005 Apr 12. J Infect Dis. 2005. PMID: 15838796

10

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.

Winston A, Bloch M, Carr A, Amin J, Mallon PW, Ray J, Marriott D, Cooper DA, Emery S. Winston A, et al. Among authors: mallon pw. J Antimicrob Chemother. 2005 Aug;56(2):380-7. doi: 10.1093/jac/dki235. Epub 2005 Jul 4. J Antimicrob Chemother. 2005. PMID: 15996972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters